http://hdl.handle.net/20.500.11768/96382
Early diagnosis of lung cancer by low-dose computed tomography is an effective strategy to reduce cancer mortality in high-risk individuals. However, recruitment of at-risk individuals with asymptomatic lung cancer still remains challenging. We developed a minimal invasive serum test, based on the detection of circulating microRNAs, which can identify at-risk individuals with asymptomatic early stage non-small cell lung carcinomas with 80% accuracy.
Circulating microRNAs: next-generation biomarkers for early lung cancer detection / Bianchi, F; Nicassio, F; Veronesi, G; di Fiore, P P. - In: ECANCERMEDICALSCIENCE. - ISSN 1754-6605. - 6:(2012), pp. 246-246. [10.3332/ecancer.2012.246.]
Circulating microRNAs: next-generation biomarkers for early lung cancer detection
Veronesi G;
2012-01-01
Abstract
Early diagnosis of lung cancer by low-dose computed tomography is an effective strategy to reduce cancer mortality in high-risk individuals. However, recruitment of at-risk individuals with asymptomatic lung cancer still remains challenging. We developed a minimal invasive serum test, based on the detection of circulating microRNAs, which can identify at-risk individuals with asymptomatic early stage non-small cell lung carcinomas with 80% accuracy.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
